SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Report abuse about a comment

Sponsors involved as well

One should not forget that CROs still work for sponsors and do not conduct trials for themselves. The fact that sales outside the US have grown that much demonstrates that the big pharma , which is by far the biggest client of global CROs, is more and more interested in selling its products outside the US market. This is particularly true for emerging countries such as Brasil or India. And since it is way easier to get registration and to sell its drug, in Brasil for example, once trials have been conducted in the country, sponsors ask for CROs to have an international expansion. Therefore it is not only the CROs that are globalising, it is the whole pharma industry.

Posted by Guillaume Miara
30 August 2011 | 15h30

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: Over 50% of sales at top CROs now made outside US; report

Spotlight

ex-RPS CIO drops lawsuit after settling wrongful dismissal case

ex-RPS CIO drops wrongful dismissal lawsuit and allegations the CRO unlawfully stored applicant data

An ex RPS employee who claimed he was sacked after discovering the CRO was unlawfully storing potential...

Consort Medical to buy Aesica for £230m
update

Consort Medical cites growing Bespak as driver for £230m Aesica acquisition

Consort Medical will buy UK contractor Aesica for £230m from Silverfleet Capital in a deal announced today.

Medidata hit by $4.8m wire fraud, but says customer data is safe

Medidata hit by $4.8m wire fraud, but says customer clinical trial data is safe

Fraudsters who hoodwinked Medidata Solutions into transferring $4.8m to an "overseas" account this month did not access...

EMA opens investigation into India’s GVK Bio over ECG falsifications
Update

EMA opens investigation into India’s GVK Bio over ECG falsifications

At the request of the European Commission, the EMA (European Medicines Agency) announced Friday that it would...

AstraZeneca brings IT services in-house with new Indian facility

AstraZeneca brings IT services in-house with new Indian facility

The opening of a global IT centre in India will bring services back in-house, but AstraZeneca says...

Ukraine still attracting international trials according to new study

Ukraine still attracting Quintiles, PPD, Icon, Parexel and INC says study

Political instability in Ukraine has not diminished international drug industry desire to conduct clinical trials there according...